Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach is the first evidence–based reference text designed for the multidisciplinary team of medical professionals involved in the investigation, diagnosis, and management of patients with gastrointestinal cancer. Written and edited by leading international experts in the field it sets the standard in clinical practice for dealing with esophageal, gastric, intestinal, colonic, hepatobiliary, pancreatic, and other GI tumors.
The book is divided into twenty–five clinical chapters each addressing the specific cancers affecting the gastrointestinal tract. Each chapter is written by a team of authors, with each contributor specially chosen to represent a different role in the MDT. This multidisciplinary team approach reflects the current care of GI cancer patients and enables clinical decision making and patient management. All the chapters have been tried and tested in MDT meetings in leading cancer centers around the world.
Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach provides in–depth evidence–based knowledge and is well illustrated throughout with color photographs, line drawings, and diagrams. This authoritative and practical resource is an essential reference for the entire MDT including gastroenterologists, hepatologists, GI surgeons, medical oncologists, radiation therapists, interventional radiologists, pathologists, specialist nurses, and clinical scientists.

Spis treści:
List of Contributors.
Preface.
Foreword.
Part I: Gastroesophageal Cancer (Edited by Richard Sampliner, University of Arizona College of Medicine).
1 Epidemiology of Gastroesophageal Cancer (Evan S. Dellon, University of North Carolina School of Medicine and Nicholas J. Shaheen, University of North Carolina School of Medicine).
2 Factors involved in Carcinogenesis and Prevention (Mark R. Anderson, City Hospital, Bir mingham and Janusz Jankowski, University of Oxford).
3 Molecular Biology of Gastroesophageal Cancers: The Role of Mutational Analysis in Prognosis (Matthew Lovell, St Bartholomew’s and the London School of Medicine and Dentistry; Chetan Bhan, Eastbourne Hospital; Janusz Jankowski and Stuart McDonald, University of Oxford).
4 Esophageal Adenocarcinoma (Edited by Kenneth K. Wang, Department of Gastroenterology and Hepatology, Rochester, USA).
Diagnosis.
Endoscopic diagnosis of Barrett’s esophagus (Vidu B. Mokkala, Mayo Clinic, Rochester, USA; Navtej S. Buttar, Mayo Clinic, Rochester, USA; and Louis M. Wong Kee Song, Mayo Clinic, Rochester, USA).
The histologic diagnosis of Barrett’s esophagus (Thomas C. Smyrk, Mayo Clinic, Rochester, USA and Navtej S. Buttar, Mayo Clinic, Rochester, USA).
Staging of esophageal cancer (Ananya Das, Mayo Clinic Arizona and Amitabh Chak, Case Western Reserve University School of Medicine).
Treatment.
Overview (Kenneth K. Wang, Mayo Clinic, Rochester, USA).
Surgical management of esophageal carcinoma (Daniela Molena, University of Rochester Medical Center, USA; Fernando Herbella, University of Rochester, USA; and Jeffrey H. Peters, University of Rochester, USA).
Chemotherapy for metastatic cancer of the esophagus, gastroesophageal junction, and stomach (Aminah Jatoi, Mayo Clinic, Rochester, USA).
Concurrent radiochemotherapy for esophageal cancer: Zhongxing Liao (The University of Texas M. D. Anderson Cancer Center), Luka Milas (The University of Texas M. D. Anderson Cancer Center), Ritsuko Komaki (Anderson Cancer Center, Houston) & Jaffer Ajani (University of Texas MD Anderson Cancer Center).
Ablation, novel agents, and endoscopic therapy for esophageal dysplasia and carcinoma: Herbert C. Wolfsen (Mayo Clinic College of Medicine, Rochester, USA).
Prognosis and follow–up: Kenneth K. Wang (Mayo Clinic, Rochester, USA).
5 Squamous Cancer of the Esophagus: Edited by Hugh Barr (Gloucestershire Royal Hospital).
Diagnosis.
History and etiology: Alastair Sammon (Gloucestershire Hospitals NHS Foundation Trust) & Mark Vipond (Gloucestershire Royal NHS Foundation Trust).
Clinical: Alastair Sammon (Gloucestershire Hospitals NHS Foundation Trust) & Mark Vipond (Gloucestershire Royal NHS Foundation Trust).
Histopathology and staging: Salim Anjarwalla (Gloucestershire Royal Hospital), David Hewin (Gloucestershire Royal Hospital) & Neil A. Shepherd (Gloucestershire Royal Hospital).
Imaging and clinical staging: David Hewin (Gloucestershire Royal Hospital), Neil A. Shepherd (Gloucestershire Royal Hospital) & Salim Anjarwalla (Gloucestershire Royal Hospital).
Treatment.
Overview: Hugh Barr (Gloucestershire Royal Hospital).
Surgery: Ferdinandos Skoulidis (University of Cambridge), Yu Jo Chua (Royal Marsden Hospital, Surrey) & David Cunningham (John Radcliffe Hospital, Oxford).
Chemotherapy: Ferdinandos Skoulidis (University of Cambridge), Yu Jo Chua (Royal Marsden Hospital, Surrey) & David Cunningham (John Radcliffe Hospital, Oxford).
Radiotherapy: Ferdinandos Skoulidis (University of Cambridge), Yu Jo Chua (Royal Marsden Hospital, Surrey) & David Cunningham (John Radcliffe Hospital, Oxford).
Ablation of early cancer: Hugh Barr (Gloucestershire Royal Hospital).
Palliation and endoscopic therapy: Hugh Barr (Gloucestershire Royal Hospital).
Novel agents: Ferdinandos Skoulidis (University of Cambridge), Yu Jo Chua (Royal Marsden Hospital, Surrey) & David Cunningham (Royal Marsden Hospital, Surrey).
Prognosis and follow–up: Hugh Barr (Gloucestershire Royal Hospital).
6 Diffuse Gastric Cancer: Edited by Ilfet Songun (Leiden University Medical Center) & Cornelius van de Velde (Leiden University Medical Center).
Diagnosis.
History: Ilfet Songun (Leiden Un iversity Medical Center) & Cornelius van de Velde (Leiden University Medical Center).
Clinical: Annemieke Cats (Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital).
Histopathology and molecular pathology: Cen Si (Vrije Universiteit Medical Center, Amsterdam), Nicole C.T. van Grieken (Vrije Universiteit Medical Center, Amsterdam) & Gerrit A. Meijer (Vrije Universiteit Medical Center, Amsterdam).
Imaging and staging of gastric cancer: Regina G.H. Beets–Tan (University Hospital Maastrict) & Cornelius van de Velde (Leiden University Medical Center).
Treatment.
Overview: Ilfet Songun (Leiden University Medical Center) & Cornelius van de Velde (Leiden University Medical Center).
Surgery: Ilfet Songun (Leiden University Medical Center) & Cornelius van de Velde (Leiden University Medical Center).
Chemotherapy: Christopher Jackson (Royal Marsden Hospital, Surrey), Naureen Starling (Royal Marsden Hospital, Surrey) & David Cunningham (Royal Marsden Hospital, Surrey).
Radiotherapy: Edwin P.M. Jansen (The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital) & Marcel Verheij (The Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital).
Novel agents: Annemieke Cats (Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital).
Prognosis and follow–up: Ilfet Songun (Leiden University Medical Center) & Cornelius van de Velde (Leiden University Medical Center).
7 Intestinal Gastric Cancer: Edited by Benjamin C.Y. Wong (University of Hong Kong).
Diagnosis: history, clinical and histopathology: Annie O. O. Chan (Queen Mary Hospital, Hong Kong) & Asif Rashid (MD Anderson Cancer Center, Houston).
Imaging and staging: Annie O.O. Chan (Queen Mary Hospital, Hong Kong) & Benjamin C.Y. Wong (University of Hong Kong).
Treatment: Annie O.O. Chan (Queen Mary Hospital, Hong Kong) & Benjamin C.Y. Wong (University of Hong Ko